This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Asked how he made the shift from working out the structure of proteins and how molecules bind to those proteins, to the founding of pharmaphorum and focusing on the digital space, his answer was clear: communication. Tunnah realised, in fact, that that communicative passion lay within himself and wasn’t satisfied by academic work.
There are so many different types of careers within the field of pharmacy—from research and drugdevelopment to pharmacy informatics! It also improves care coordination and eliminates communication gaps. It involves the training of community paramedics in performing some aspects of medication reconciliation.
In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. In addition to these issues, further barriers to drug access remain in the UK and US.
In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. In addition to these issues, further barriers to drug access remain in the UK and US.
2025 Health Leadership Conference takes on The Future of Leadership January 22, 2025 By: Leah Poffenberger, Senior Manager, Communications Leadership health care often comes with unique challenges in an ever-changing ecosystem.
Storing fat around the tummy is a well-recognised risk factor for diabetes, heart attacks and strokes, even in people who have normal-range body mass index (BMI) and are not overweight. Some readers may recall the excitement generated by the discovery of leptin in the 1990s, a hormone involved in signalling satiety, or a feeling of fullness.
The two-day retreat was jam-packed with opportunities for attendees to hear from policy and regulatory experts, share organizational challenges and successes, and network with peers.
In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.
Behind-the-scenes research lab videos showcasing drugdevelopment. Chatbots answering FAQs on drug safety and usage. For instance, a diabetesdrug brand can create a personalized nutrition plan generator based on patient dietary preferences and blood sugar levels. Medication trackers & digital health guides.
Now, in this hunt for new drugs, small to medium enterprises (SMEs) are also taking their chances in the quickly growing marketplace, with new methods of targeting obesity. This topic was at the forefront of a panel on obesity drugdevelopment. However, several challenges remain in the field of obesity drugdevelopment.
Patients with conditions with limited treatment options could one day be cured by these breakthrough therapeutics, with treatments for everything from cancers, Parkinson’s and Alzheimer’s to strokes, spinal cord injuries and diabetes. We are all aligned and in frequent communication with each other.
Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drugdevelopment consultancy Boyds. So, living with diabetes, living with multiple sclerosis, living with ovarian cancer.” But who is benefitting?
The Future of Generic DrugDevelopment: Opportunities and Challenges for Emerging Markets As the global healthcare landscape continues to evolve, emerging markets are playing an increasingly important role in shaping the future of generic drugdevelopment. Share your thoughts in the comments below!
It now offers DPN patients relief from chronic pain through low doses of stimulation & the battery lasts up to 10 years at low-dose settings The system also pairs with Abbott’s NeuroSphere Virtual Clinic, a connected care app for people to communicate with a physician and receive remote treatment adjustments.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content